» Articles » PMID: 33440126

Role of MALDI-MSI in Combination with 3D Tissue Models for Early Stage Efficacy and Safety Testing of Drugs and Toxicants

Overview
Publisher Informa Healthcare
Date 2021 Jan 13
PMID 33440126
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

: Three-dimensional (3D) cell cultures have become increasingly important materials to investigate biological processes and drug efficacy and toxicity. The ability of 3D cultures to mimic the physiology of primary tissues and organs in the human body enables further insight into cellular behavior and is hence highly desirable in early-stage drug development. Analyzing the spatial distribution of drug compounds and endogenous molecules provides an insight into the efficacy of a drug whilst simultaneously giving information on biological responses. : In this review we will examine the main 3D cell culture systems employed and applications, which describe their integration with mass spectrometry imaging (MSI). : MSI is a powerful technique that can map a vast range of molecules simultaneously in tissues without the addition of labels that can provide insights into the efficacy and safety of a new drug. The combination of MSI and 3D cell cultures has emerged as a promising tool in early-stage drug analysis. However, the most common administration route for pharmaceutical drugs is via oral delivery. The use of MSI in combination with models of the GI tract is an area that has been little explored to date, the reasons for this are discussed.

Citing Articles

The Use of Patient-Derived Organoids in the Study of Molecular Metabolic Adaptation in Breast Cancer.

Glibetic N, Bowman S, Skaggs T, Weichhaus M Int J Mol Sci. 2024; 25(19).

PMID: 39408832 PMC: 11477048. DOI: 10.3390/ijms251910503.


Development of a Mass Spectrometry Imaging Method to Evaluate the Penetration of Moisturizing Components Coated on Surgical Gloves into Artificial Membranes.

Nagano E, Odake K, Akiyoshi T, Shimma S Mass Spectrom (Tokyo). 2024; 13(1):A0145.

PMID: 38577169 PMC: 10990723. DOI: 10.5702/massspectrometry.A0145.


Quantitative mass spectrometry imaging: therapeutics & biomolecules.

Holbrook J, Kemper G, Hummon A Chem Commun (Camb). 2024; 60(16):2137-2151.

PMID: 38284765 PMC: 10878071. DOI: 10.1039/d3cc05988j.


Lipidomic Phenotyping Of Human Small Intestinal Organoids Using Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.

Duivenvoorden A, Claes B, van der Vloet L, Lubbers T, Glunde K, Olde Damink S Anal Chem. 2023; 95(50):18443-18450.

PMID: 38060464 PMC: 10733903. DOI: 10.1021/acs.analchem.3c03543.


Perspective: Mass Spectrometry Imaging - The Next 5 Years.

Clench M, Cole L Methods Mol Biol. 2023; 2688:203-210.

PMID: 37410295 DOI: 10.1007/978-1-0716-3319-9_17.


References
1.
Harvey A, Cole L, Day R, Bartlett M, Warwick J, Bojar R . MALDI-MSI for the analysis of a 3D tissue-engineered psoriatic skin model. Proteomics. 2016; 16(11-12):1718-25. PMC: 5094548. DOI: 10.1002/pmic.201600036. View

2.
Bartosh T, Ylostalo J, Mohammadipoor A, Bazhanov N, Coble K, Claypool K . Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A. 2010; 107(31):13724-9. PMC: 2922230. DOI: 10.1073/pnas.1008117107. View

3.
Ekins S, Mestres J, Testa B . In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol. 2007; 152(1):9-20. PMC: 1978274. DOI: 10.1038/sj.bjp.0707305. View

4.
Russo C, Brickelbank N, Duckett C, Mellor S, Rumbelow S, Clench M . Quantitative Investigation of Terbinafine Hydrochloride Absorption into a Living Skin Equivalent Model by MALDI-MSI. Anal Chem. 2018; 90(16):10031-10038. DOI: 10.1021/acs.analchem.8b02648. View

5.
Russo C, Lewis E, Flint L, Clench M . Mass Spectrometry Imaging of 3D Tissue Models. Proteomics. 2018; 18(14):e1700462. DOI: 10.1002/pmic.201700462. View